Image

Effects of Smoking Addiction on Lower Limb Speed and Coordination

Effects of Smoking Addiction on Lower Limb Speed and Coordination

Recruiting
18-25 years
All
Phase N/A

Powered by AI

Overview

This observational case-control study will investigate the impact of smoking addiction on lower extremity speed and coordination in young adults. Participants aged 18-25 will be divided into two groups based on their smoking status. The study will compare motor coordination and sprint performance between smokers and non-smokers using objective physical tests under standardized laboratory conditions.

Description

This non-randomized controlled study will aim to evaluate the effects of smoking addiction on the speed and coordination of lower extremity movements among healthy young adults. Smoking is known to have detrimental effects on vascular, musculoskeletal, and neurological systems, yet its impact on motor performance-particularly in the lower limbs-has not been sufficiently studied.

Participants aged 18-25 will be categorized into smoker and non-smoker groups based on DSM-IV-TR nicotine dependence criteria and the Fagerström Test. The Lower Extremity Motor Coordination Test (LEMOCOT) will be used to assess motor coordination, while a 30-meter sprint test will evaluate movement speed. Additionally, body mass index (BMI) and bimalleolar diameter and circumference will be recorded to control for confounding physical variables.

All assessments will be conducted in a controlled laboratory environment. The results will be analyzed to determine whether smoking addiction is associated with impaired lower limb motor function. The findings may provide new insights into the functional consequences of smoking in young adults and contribute to the design of preventive and rehabilitative strategies.

Eligibility

Inclusion Criteria:

  • Smoking ≥1 cigarette daily for at least 12 months
  • Age between 18-25
  • Literate and cooperative
  • BMI: 18.5-29.9 kg/m²

Exclusion Criteria:

  • Orthopedic, neurological, or neuromuscular conditions impairing walking
  • Chronic pulmonary or cardiac disease
  • Cognitive impairment
  • BMI ≥30 kg/m²

Study details
    Smoking Cessation

NCT07061522

Saglik Bilimleri Universitesi

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.